Marinus Pharmaceuticals Inc (MRNS):企業の財務・戦略的SWOT分析

◆英語タイトル:Marinus Pharmaceuticals Inc (MRNS) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH141470FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Marinus Pharmaceuticals Inc (Marinus Pharmaceuticals) is a biopharmaceutical company which discovers, develops and commercializes medicines for the treatment of epilepsy and other neuropsychiatric disorders. The company is evaluating its lead product candidate Ganaxolone, a gamma-aminobutyric acid (GABA) modulator, against status epilepticus (SE), cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder, PCDH19-related epilepsy and tuberous sclerosis complex (TSC). It works in collaboration with The Tuberous Sclerosis Alliance, Postpartum Support International, Epilepsy Foundation of America and PCDH19 Alliance for advancing its therapeutics. Marinus is headquartered in Radnor, Pennsylvania, the US.

Marinus Pharmaceuticals Inc Key Recent Developments

Mar 24,2021: Marinus Pharmaceuticals Appoints Dr. Saraswathy (Sara) Nochur to Board of Directors
Feb 23,2021: Marinus Pharmaceuticals Unveils New Brand as the Company Prepares for Commercialization
Feb 23,2021: Marinus Pharmaceuticals unveils new brand as the company prepares for commercialization
Feb 17,2021: Marinus Pharmaceuticals to Participate in Multiple Investor Healthcare and Life Sciences Conferences
Dec 21,2020: Marinus Pharmaceuticals announces Iis addition to the Nasdaq Biotechnology Index

This comprehensive SWOT profile of Marinus Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Marinus Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Marinus Pharmaceuticals Inc – Key Information
Marinus Pharmaceuticals Inc – Overview
Marinus Pharmaceuticals Inc – Key Employees
Marinus Pharmaceuticals Inc – Key Employee Biographies
Marinus Pharmaceuticals Inc – Key Operational Heads
Marinus Pharmaceuticals Inc – Major Products and Services
Marinus Pharmaceuticals Inc – History
Marinus Pharmaceuticals Inc – Company Statement
Marinus Pharmaceuticals Inc – Locations And Subsidiaries
Marinus Pharmaceuticals Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Marinus Pharmaceuticals Inc – Business Description
Marinus Pharmaceuticals Inc – Corporate Strategy
Marinus Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Marinus Pharmaceuticals Inc – Strengths
Marinus Pharmaceuticals Inc – Weaknesses
Marinus Pharmaceuticals Inc – Opportunities
Marinus Pharmaceuticals Inc – Threats
Marinus Pharmaceuticals Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Marinus Pharmaceuticals Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Marinus Pharmaceuticals Inc, Key Information
Marinus Pharmaceuticals Inc, Key Ratios
Marinus Pharmaceuticals Inc, Share Data
Marinus Pharmaceuticals Inc, Major Products and Services
Marinus Pharmaceuticals Inc, History
Marinus Pharmaceuticals Inc, Key Employees
Marinus Pharmaceuticals Inc, Key Employee Biographies
Marinus Pharmaceuticals Inc, Key Operational Heads
Marinus Pharmaceuticals Inc, Other Locations
Marinus Pharmaceuticals Inc, Subsidiaries
Marinus Pharmaceuticals Inc, Key Competitors
Marinus Pharmaceuticals Inc, SWOT Analysis
Marinus Pharmaceuticals Inc, Ratios based on current share price
Marinus Pharmaceuticals Inc, Annual Ratios
Marinus Pharmaceuticals Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Marinus Pharmaceuticals Inc (MRNS):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Atkore International Group Inc (ATKR):企業の財務・戦略的SWOT分析
    Atkore International Group Inc (ATKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Mercy:企業の戦略的SWOT分析
    Mercy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This u …
  • Zeltiq Aesthetics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Zeltiq Aesthetics Inc (Zeltiq), formerly Juniper Medical Inc, a subsidiary of Allergan Plc, is a medical technology company that develops and commercializes non-invasive products for the reduction of fat, selectively. The company offers CoolSculpting system, which uses proprietary controlled …
  • TeleTech Holdings, Inc. (TTEC):企業の財務・戦略的SWOT分析
    TeleTech Holdings, Inc. (TTEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Bord na Mona Plc:企業の戦略的SWOT分析
    Bord na Mona Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Del Taco Holdings, Inc.:企業の戦略・SWOT・財務情報
    Del Taco Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Del Taco Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Fairfax Financial Holdings Limited:企業のM&A・事業提携・投資動向
    Fairfax Financial Holdings Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Fairfax Financial Holdings Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on m …
  • QEP Resources, Inc.:企業の戦略・SWOT・財務情報
    QEP Resources, Inc. - Strategy, SWOT and Corporate Finance Report Summary QEP Resources, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Virginia Electric and Power Company:電力:M&Aディール及び事業提携情報
    Summary Virginia Electric and Power Company (Virginia Power), formerly Virginia Public Service Corporation, is a regulated energy utility that generates, transmits, and distributes electricity. It generates electricity from gas, nuclear, oil, coal, renewable, and biomass sources. The company also pr …
  • Reach Subsea ASA (REACH):企業の財務・戦略的SWOT分析
    Reach Subsea ASA (REACH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • NetSol Technologies, Inc. (NTWK):企業の財務・戦略的SWOT分析
    NetSol Technologies, Inc. (NTWK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Vaccinex Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Vaccinex Inc (Vaccinex) is a clinical-stage biotechnology company that discovers and develops targeted biotherapeutics to treat neurodegenerative diseases, cancer and autoimmune disorders. The company’s lead platform technologies include antibody platform and ActivMAb, SEMA4D, and antibody d …
  • Asatsu-DK Inc.:企業の戦略的SWOT分析
    Asatsu-DK Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • ZH International Holdings Ltd:企業の戦略・SWOT・財務情報
    ZH International Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary ZH International Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Richardson Electronics Ltd (RELL):企業の財務・戦略的SWOT分析
    Summary Richardson Electronics Ltd (Richardson Electronics) manufactures electron tube. It offers engineered solutions, power grid and microwave tubes and consumables, displays, flat panel detector solutions and parts for diagnostic imaging equipment, power conversion and RF and microwave components …
  • Teradyne Inc (TER):企業の財務・戦略的SWOT分析
    Teradyne Inc (TER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • GENTEX Corp:企業の戦略的SWOT分析
    GENTEX Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Pt Pioneerindo Gourmet International Tbk
    Pt Pioneerindo Gourmet International Tbk - Strategy, SWOT and Corporate Finance Report Summary Pt Pioneerindo Gourmet International Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Nidec Corporation:企業の戦略・SWOT・財務分析
    Nidec Corporation - Strategy, SWOT and Corporate Finance Report Summary Nidec Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Masimo Corp (MASI):企業の財務・戦略的SWOT分析
    Masimo Corp (MASI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆